Wolverine Asset Management’s Novavax NVAX Stock Holding History

Wolverine Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,400	Closed	-$220K	–	2020
2022 Q4	$220K	Buy	21,400 +5,700	+36%	+$101K	﹤0.01%	1131
2022 Q3	$285K	Hold	15,700	–	–	﹤0.01%	1170
2022 Q2	$807K	Buy	15,700 +10,000	+175%	+$518K	0.01%	857
2022 Q1	$419K	Buy	5,700 +5,600	+5,600%	+$499K	﹤0.01%	1024
2021 Q4	$14K	Hold	100	–	–	﹤0.01%	1797
2021 Q3	$20K	Hold	100	–	–	﹤0.01%	1634
2021 Q2	$21K	Hold	100	–	–	﹤0.01%	1895
2021 Q1	$18K	Buy	+100	New	+$19.9K	﹤0.01%	1779
2019 Q2	–	Sell	-355	Closed	-$3K	–	1552
2019 Q1	$3K	Buy	355 +55	+18%	+$1.74K	﹤0.01%	1307
2018 Q4	$11K	Buy	+300	New	+$11.6K	﹤0.01%	1530
2017 Q1	–	Sell	-1,535	Closed	-$38K	–	1327
2016 Q4	$38K	Sell	1,535 -465	-23%	-$13.6K	﹤0.01%	1035
2016 Q3	$83K	Buy	2,000 +800	+67%	+$103K	﹤0.01%	996
2016 Q2	$174K	Buy	+1,200	New	+$138K	﹤0.01%	894

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Wolverine Asset Management's NVAX Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in Novavax (NVAX) in Q2 2026: 37,037 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in NVAX as recently as Q4 2023.

Wolverine Asset Management first reported a position in NVAX in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.43M in Q1 2023. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Wolverine Asset Management held 37,037 shares of Novavax worth $349K as of Q2 2026.
Novavax was a new Wolverine Asset Management position in Q2 2026.
Novavax made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1017 holding.
Wolverine Asset Management first reported a position in Novavax in Q4 2018 and has held it in 12 quarters since.
Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.